Trastuzumab Recruiting Phase 2 Trials for Esophageal Cancers / Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02725424Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy